Cytochrome P450, Family 27, Subfamily A, Polypeptide 1 (CYP27A1) ELISA Kits

CYP27A1 encodes a member of the cytochrome P450 superfamily of enzymes. Additionally we are shipping CYP27A1 Antibodies (89) and CYP27A1 Proteins (5) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
CYP27A1 1593 Q02318
CYP27A1 301517 P17178
CYP27A1 104086 Q9DBG1
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top CYP27A1 ELISA Kits at

Showing 3 out of 7 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 0.055 ng/mL 0.15 ng/mL - 10 ng/mL 96 Tests 13 to 16 Days
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days

Top referenced CYP27A1 ELISA Kits

  1. Human CYP27A1 ELISA Kit for Sandwich ELISA - ABIN419215 : Zhao, Li, Wang, Habib, Wei, Sun, Strobel, Jia: Vitamin D serum level is associated with Child-Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients. in Medicine 2016 (PubMed)

More ELISA Kits for CYP27A1 Interaction Partners

Human Cytochrome P450, Family 27, Subfamily A, Polypeptide 1 (CYP27A1) interaction partners

  1. Study found no statistically significant associations of HCV infection outcomes with CYP27A1 gene.

  2. analysis of the role of CYP27A1, CYP27B1, and CYP24A1 in non-melanoma skin cancer reveals that the expression of CYP27A1 and CYP24A1, but not CYP27B1 is changed in malignant cells

  3. Donor/recipient CYP27A1 rs4674344 and graft VDR rs2228570 may be related to low serum 25(OH)D and may play a major role in the development of fatty liver disease in recipients after living donor liver transplantation.

  4. CYP27A1 SNPs are not associated with vitamin D status and multiple sclerosis.

  5. Vitamin D supplementation can decrease circulating 27HC of breast cancer patients, likely by CYP27A1 inhibition. This suggests a new and additional modality by which vitamin D can inhibit ER+ breast cancer growth, though a larger study is needed for verification.

  6. Whole-exome sequencing assuming recessive inheritance determined his genetic diagnosis to be cerebrotendinous xanthomatosis caused by homozygous mutations (c.410G>A or p.Arg137Gln) in the cytochrome P450 subfamily 27 A1 (CYP27A1) gene

  7. Three novel mutations in CYP27A1 were found in cerebrotendinous xanthomatosis patients in Chinese families

  8. Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia

  9. Molecular study identified a novel homozygous frameshift mutation in CYP27A1 gene in cerebrotendinous xanthomatosis without cataract

  10. Cerebrotendinous xanthomatosis .. is caused by mutations in the CYP27A1 gene that result in decreased production of chenodeoxycholic acid (CDCA) and elevated levels of cholestanol and bile alcohols. Sequencing of CYP27A1 showed a paternally inherited splice mutation, c.446 + 1G>T, and a maternally inherited nonsense mutation, c.808C>T, predicting p.(Arg270*).

  11. we demonstrated the rare missense variant of CYP27A1 is associated with atopic dermatitis with elevated levels of total serum IgE.

  12. The 32 kb deleted region harbors the CYP2A7 gene and was enriched with enhancer, repressor and insulator sites. The wildtype allele was lost in the polyps of the proband

  13. CYP27A1 is a critical cellular cholesterol sensor in prostate cells and that dysregulation of the CYP27A1/27-hydroxycholesterol (27HC) axis contributes significantly to prostate cancer pathogenesis.

  14. CYP27A1 catalyzes hydroxylation of beta-sitosterol and ergosterol

  15. This study suggests a shared genetic etiology between MS and the characterized single-gene disorders, and highlights cholesterol metabolism and the synthesis of oxysterols as important biological mechanisms for familial MS

  16. CYP46A1 is involved in cholestanol removal from the brain and that several factors contribute to the preferential increase in cholestanol in the cerebellum arising from CYP27A1 deficiency.

  17. A significant decrease in the expression level of CYP27A1 in female patients could indicate their greater vulnerability to multiple sclerosis than the male patients.

  18. A novel mutation (c.1183_1184insT) in several members of a Colombian cerebrotendinous xanthomatosis family is responsible for mental retardation, psychiatric disorders, behavioral changes, and multiple domains cognitive impairment with dysexecutive dominance that progressed to early dementia.

  19. CYP27A1 belongs to the mitochondrial CYPs and plays a crucial role in the cholesterol homeostasis.

  20. Analysis of ~60,000 human exomes points to underdiagnosis of cerebrotendinous xanthomatosis due to CYP27A1 mutations.

Mouse (Murine) Cytochrome P450, Family 27, Subfamily A, Polypeptide 1 (CYP27A1) interaction partners

  1. In het mice, RIF had no effect on plasma lipids composition, CYP27A1 activity, and atherosclerotic plaque development, despite a reduction in cholesterol absorption. In conclusion, the antiatherogenic effect of Cyp3a11 induction by RIF was also dependent on Cyp27a1 expression.

  2. CYP46A1 is involved in cholestanol removal from the brain and that several factors contribute to the preferential increase in cholestanol in the cerebellum arising from CYP27A1 deficiency.

  3. The cholesterol diet reduced the levels of the "memory protein" Arc (Activity Regulated Cytoskeleton associated protein) in the hippocampus of the wildtype mice but not in the hippocampus of the Cyp27-/- mice.

  4. overexpression of Cyp27a1 in KCs reduces hepatic inflammation independently of 27HC levels in plasma and liver, further pointing towards KCs as specific target for improving the therapy of NASH.

  5. Data indicate that inhibition of CYP27A1 activity or knockdown and deletion of the Cyp27a1 gene induced adipocyte differentiation.

  6. The expression of CYP27A1 modulates the concentrations of active glucocorticoids in both humans and mice and in vitro.

  7. Loss of CYP27A1 led to dysregulation of retinal cholesterol homeostasis, including unexpected upregulation of retinal cholesterol biosynthesis. Cyp27a1-/- mice developed retinal lesions with cholesterol deposition beneath the retinal pigment epithelium.

  8. CYP27(-/-) mice exhibited enhanced CCl(4)-induce liver injury, and defective liver regeneration and prolonged steatosis after 70% partial hepatectomy.

  9. Results are consistent with a concentration-dependent flux of 7alpha-hydroxy-4-cholesten-3-one across the blood-brain barrier in cyp27a1(-/-) mice and subsequent formation of cholestanol.

  10. Increasing 27-hydroxycholesterol concentrations by genetic means alters bone mineral density.

  11. In CYP27A1 ko mice, urinary progesterone concentrations were decreased, 20alpha-DH-progesterone increased, and the progesterone-to-20alpha-DH-progesterone ratio decreased threefold

  12. mice do not have an absolute requirement for 27OHase in order to metabolise 7-ketocholesterol and must rely on alternative side-chain oxidising pathways

  13. both cyp27A genotype and gender affected the regulation of hepatic bile acid, cholesterol, and fatty acid metabolism

  14. Hepatic neutral cytosolic cholesteryl ester hydrolase decreased mRNAs for cholesterol 7alpha-hydroxylase, sterol 27-hydroxylase, and HMG-CoA reductase on day 7 after transfection, coinciding with peak hepatic free cholesterol concentrations

Cow (Bovine) Cytochrome P450, Family 27, Subfamily A, Polypeptide 1 (CYP27A1) interaction partners

  1. isoLG adduction impairs enzyme activity, and support our hypothesis that isoLG modification in the retina is detrimental to CYP27A1 enzyme activity, potentially disrupting cholesterol homeostasis.

  2. Features of the retinal environment which affect the activities and product profile of cholesterol-metabolizing cytochromes P450 CYP27A1 and CYP11A1.

  3. Sterol 27-hydroxylase cytochrome P450 27A1 (CYP27A1) is involved in elimination of 7-ketocholesterol from the retinal pigment epithelium.

CYP27A1 Antigen Profile

Antigen Summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease.

Gene names and symbols associated with CYP27A1

  • cytochrome P450 family 27 subfamily A member 1 (CYP27A1) antibody
  • cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1) antibody
  • cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1) antibody
  • sterol 26-hydroxylase, mitochondrial (CYP27A1) antibody
  • cytochrome P450, family 27, subfamily A, polypeptide 1 (cyp27a1) antibody
  • 1300013A03Rik antibody
  • CP27 antibody
  • CTX antibody
  • Cyp27 antibody
  • P450C27 antibody

Protein level used designations for CYP27A1

5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol 26-hydroxylase , 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol 27-hydroxylase , 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase , cholestanetriol 26-monooxygenase , cytochrome P-450C27/25 , cytochrome P450 27 , cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 , sterol 26-hydroxylase, mitochondrial , sterol 27-hydroxylase , vitamin D(3) 25-hydroxylase , cytochrome P-450c27/25 , cholesterol 27 hydroxylase , cytochrome P450, 27 , cytochrome P450, 27a1

1593 Homo sapiens
301517 Rattus norvegicus
104086 Mus musculus
610489 Canis lupus familiaris
100126282 Sus scrofa
511960 Bos taurus
100348736 Oryctolagus cuniculus
100381137 Xenopus laevis
Selected quality suppliers for CYP27A1 (CYP27A1) ELISA Kits
Did you look for something else?